trans-Propenyl propyl disulfide
Common Name: |
trans-Propenyl propyl disulfide |
IUPAC Name: |
1-[[(E)-prop-1-enyl]disulfanyl]propane |
Molecular Formula: |
C15H22O |
SMILES: |
CCCSS/C=C/C |
Inchi: |
1S/C6H12S2/c1-3-5-7-8-6-4-2/h3,5H,4,6H2,1-2H3/b5-3+ |
Inchi Key: |
AAPBYIVJOWCMGH-HWKANZROSA-N |
Cas No: |
5905-46-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
218.33 |
Mass (g/mol) |
148.038 |
Molar Refractivity |
69.24 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
78.00 to 80.00 @ 13.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.936 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.67 |
LogP |
3.311 |
iLOGP |
2.96 |
XLOGP3 |
3.66 |
WLOGP |
3.90 |
MLOGP |
3.46 |
ESOL Log S |
-3.43 |
ESOL Solubility (mg/ml) |
0.081 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.71 |
Ali Solubility (mg/ml) |
0.04 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.44 |
Silicos-IT Solubility (mg/ml) |
0.08 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.03 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.812 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.895 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |